Entourage Health Corp.
ETRGF · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $9,545 | $9,263 | $12,701 | $9,955 |
| % Growth | 3% | -27.1% | 27.6% | – |
| Cost of Goods Sold | $6,674 | $8,070 | $6,750 | $14,334 |
| Gross Profit | $2,872 | $1,193 | $5,951 | -$4,379 |
| % Margin | 30.1% | 12.9% | 46.9% | -44% |
| R&D Expenses | $0 | $0 | $0 | -$42 |
| G&A Expenses | $3,250 | $3,913 | $4,684 | $4,275 |
| SG&A Expenses | $4,111 | $4,780 | $5,467 | $5,509 |
| Sales & Mktg Exp. | $861 | $867 | $782 | $1,235 |
| Other Operating Expenses | -$72 | -$3,587 | $23 | -$55 |
| Operating Expenses | $4,039 | $1,193 | $5,570 | $4,403 |
| Operating Income | -$1,168 | -$3,524 | $381 | -$8,782 |
| % Margin | -12.2% | -38% | 3% | -88.2% |
| Other Income/Exp. Net | -$7,205 | -$6,800 | -$6,673 | -$8,394 |
| Pre-Tax Income | -$8,372 | -$10,325 | -$6,292 | -$17,176 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$8,372 | -$10,325 | -$6,292 | -$17,176 |
| % Margin | -87.7% | -111.5% | -49.5% | -172.5% |
| EPS | -0.027 | -0.034 | -0.02 | -0.056 |
| % Growth | 19.1% | -64.2% | 63.4% | – |
| EPS Diluted | -0.027 | -0.034 | -0.02 | -0.056 |
| Weighted Avg Shares Out | 308,387 | 308,387 | 308,387 | 308,387 |
| Weighted Avg Shares Out Dil | 308,387 | 308,387 | 308,387 | 308,387 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $6,455 |
| Interest Expense | $7,110 | $6,776 | $6,696 | $6,455 |
| Depreciation & Amortization | $140 | $139 | $130 | $209 |
| EBITDA | -$1,122 | -$3,410 | $533 | -$10,491 |
| % Margin | -11.8% | -36.8% | 4.2% | -105.4% |